EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Racial disparities in the incidence and risk factors of major bleeding during extended anticoagulant therapy for venous thromboembolism

Duale Omar, Michael J Kovacs, Alejandro Lazo-Langner, David R Anderson, Susan R Kahn, Lana A Castellucci, Jeannot Schmidt, Antoine Elias, Marc Righini, Thomas L Ortel, Menno V Huisman, Marc Carrier und 6 weitere

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2025.07.026 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Duale Omar und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Anticoagulants, Healthcare Disparities, Hemorrhage, Venous Thromboembolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canada Research Chairs Program, University of Ottawa, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Guidelines recommend extended anticoagulation after a first unprovoked venous thromboembolism (VTE) for individuals at low risk of bleeding. However, racial disparities in bleeding risks during extended treatment remain understudied. OBJECTIVES: To compare risks of anticoagulant-associated bleeding and performance of a risk assessment model by racial group during extended VTE treatment. METHODS: We analyzed 2 prospective cohorts of patients (223 Black participants and 4314 White participants) with a first unprovoked/weakly provoked VTE who continued anticoagulation after ≥3 months of initial treatment. Primary outcome was adjudicated International Society on Thrombosis and Haemostasis-defined major bleeding. Secondary outcomes included intracranial hemorrhage, fatal bleeding, and clinically relevant nonmajor bleeding. We determined incidence and hazard ratios (HRs) by race, then adjusted for bleeding risk factors that included the Creatinine, Hemoglobin, Age, antiPlatelet model. RESULTS: Black participants had higher prevalence of bleeding risk factors and a 1.9-fold higher risk of major bleeding (HR, 1.87; 95% CI, 1.04-3.36) compared with White participants. Adjustment attenuated racial difference for major bleeding but not intracranial hemorrhage (adjusted HR, 2.35; 95% CI, 1.23-4.48). Among those classified as low risk by Creatinine, Hemoglobin, Age, antiPlatelet model, Black participants had numerically higher major bleeding incidence than White participants (2.5 vs 1.1 per 100 person-years). We did not observe racial disparities in fatal bleeding or clinically relevant nonmajor bleeding. CONCLUSION: Black individuals on extended anticoagulation have higher risk of major bleeding compared with White individuals. This effect appears to persist in those classified as low risk for bleeding. Risk assessment models for anticoagulant-associated bleeding that are generalizable to racialized populations are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsHealthcare DisparitiesHemorrhageVenous ThromboembolismWhite PeopleBlack PeopleAdultAgedFemaleHumansMaleMiddle AgedIncidenceProspective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

ethnic and racial minoritieshemorrhagevenous thromboembolism

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Medicine, Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Ontario, Canada.
  • Department of Medicine, Western University, London, Ontario, Canada.
  • Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Department of Medicine, McGill University, Montreal, Québec, Canada. Electronic address: https://x.com/SusanRKahn1.
  • Department of Medicine, Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada. Electronic address:…
  • Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont, France.

Förderung

  • Canada Research Chairs Program
  • University of Ottawa
  • Canadian Institutes of Health Research
  • Heart and Stroke Foundation of Canada
  • Ministère des Solidarités et de la Santé
  • bioMérieux
  • Ottawa Hospital Research Institute

Zitieren

APA

Omar, D., Kovacs, M. J., Lazo-Langner, A., Anderson, D. R., Kahn, S. R., Castellucci, L. A., Schmidt, J., Elias, A., Righini, M., Ortel, T. L., Huisman, M. V., Carrier, M., Cénat, J. M., Mallick, R., Rodger, M. A., Le Gal, G., Wells, P. S., & Xu, Y. (2025). Racial disparities in the incidence and risk factors of major bleeding during extended anticoagulant therapy for venous thromboembolism. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.07.026

Vancouver

Omar D, Kovacs MJ, Lazo-Langner A, Anderson DR, Kahn SR, Castellucci LA, et al. Racial disparities in the incidence and risk factors of major bleeding during extended anticoagulant therapy for venous thromboembolism. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.07.026

BibTeX
@article{Omar2025,
  author = {Omar, Duale and Kovacs, Michael J and Lazo-Langner, Alejandro and Anderson, David R and Kahn, Susan R and Castellucci, Lana A and Schmidt, Jeannot and Elias, Antoine and Righini, Marc and Ortel, Thomas L and Huisman, Menno V and Carrier, Marc and Cénat, Jude-Mary and Mallick, Ranjeeta and Rodger, Marc A and Le Gal, Grégoire and Wells, Philip S and Xu, Yan},
  title = {Racial disparities in the incidence and risk factors of major bleeding during extended anticoagulant therapy for venous thromboembolism},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2025.07.026}
}
Kostenlos starten →